Artikel,

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

, , , , , , , , , , , , , , , , , , , , , , , , , , , und .
Journal for ImmunoTherapy of Cancer, 10 (5): e003487 (Mai 2022)
DOI: 10.1136/jitc-2021-003487

Metadaten

Tags

Nutzer

  • @scadsfct

Kommentare und Rezensionen